GlassScriptPhysician profile
Gillian Althea Jacob
NPI 1285617498
$1,168.84
in general payments reported to CMS, 2019-2025
21 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $107 · 2021: $102 · 2022: $181 · 2023: $226 · 2024: $195 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.98 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $234.70 | 2019-2023 | |
| Astellas Pharma US INC | $164.80 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $94.05 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $93.94 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $84.60 | 2024-2025 | |
| Sage Therapeutics, LLC | $79.32 | 2024-2025 | Zurzuvae |
| Organon LLC | $59.11 | 2022 | |
| Coopersurgical, INC. | $58.48 | 2020-2024 | Paragard T 380a |
| Renovia INC | $55.56 | 2020 | |
| Supernus Pharmaceuticals, INC. | $33.09 | 2025 | Qelbree |
| Amag Pharmaceuticals, INC. | $31.35 | 2019 | |
| Avion Pharmaceuticals | $25.94 | 2019-2021 | |
| Therapeuticsmd, INC. | $21.71 | 2021 | |
| Mayne Pharma Commercial LLC | $20.05 | 2023 | |
| Daiichi Sankyo INC. | $17.59 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.50 | 2019 | |
| Hologic Sales and Service, LLC | $16.47 | 2022 | |
| Mylan Pharmaceuticals INC. | $16.25 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $16.23 | 2023 | Vivjoa |
| Evofem Biosciences, INC. | $15.75 | 2021 | |
| Millicent US INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gillian Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.